Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Management of Children Aged Less Than 3 Years With Brain Tumors
Authors not listed
Children's Cancer and Leukaemia Group · 1992
Abstract
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy after chemotherapy may kill any remaining tumor cells.
PURPOSE: This phase II trial is studying how well giving combination chemotherapy together with or without radiation therapy works in treating children with brain tumors.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Anonymous. (1992). Management of Children Aged Less Than 3 Years With Brain Tumors. <em>Children's Cancer and Leukaemia Group</em>. https://clinicaltrials.gov/study/NCT00281905
Vancouver
Anonymous. Management of Children Aged Less Than 3 Years With Brain Tumors. Children's Cancer and Leukaemia Group. 1992.
BibTeX
@misc{anon1992Manage,
title = {Management of Children Aged Less Than 3 Years With Brain Tumors},
author = {Anonymous},
journal = {Children's Cancer and Leukaemia Group},
year = {1992},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aichi Cancer Center 2004
Open access · US-GOV
Multi-Institutional Phase II Study of Weekly Docetaxel and Concurrent Radiotherapy for Laryngeal and Hypopharyngeal Cancer in the Group of Elderly and/or Patients With Medical Illness
Canadian Cancer Trials Group 2007
Open access · US-GOV
A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients
German High-Grade Non-Hodgkin's Lymphoma Study Group 2002
Open access · US-GOV
Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Prognoses
German High-Grade Non-Hodgkin's Lymphoma Study Group 2004
Open access · US-GOV
2-Weekly CHOP Chemotherapy With Dose-Dense Rituximab for the Treatment of Patients Aged 61 to 80 Years With Aggressive CD-20 Positive B-Cell Lymphomas: A Phase-II/Pharmacokinetic Study (CHOP-R-ESC)
German High-Grade Non-Hodgkin's Lymphoma Study Group 2005
Open access · US-GOV
Randomized Study Comparing 4 and 6 Cycles of Chemotherapy With CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) at 21-day Intervals, Both With 6 Cycles of Immunotherapy With the Monoclonal Anti-CD20-Positive B-Cell Lymphoma Aged 18-60 Years Having no Risk Factor (Age-Adjusted IPI=0) and No Large Tumor Mass (Diameter <7,5cm) [FLYER 6-6-6-4 Study]
Jonsson Comprehensive Cancer Center 2010
Open access · US-GOV